Intraperitoneal administration of BMP9 in mice with high-fat diet-induced obesity results in significant browning of subcutaneous WAT, leading to reduced weight gain, smaller white adipocytes and decreased fasting blood glucose levels [153]. The gene discussed is GDF2; the disease is obesity disorder.